CAS Medical Systems, Inc. to Present at the
FBR Capital Markets Growth Conference
Branford, Conn. May 20, 2008 CAS Medical Systems, Inc. (NASDAQ: CASM), a medical device company focused on innovative, non-invasive monitoring that is vital to patient care, today announced that Andrew E. Kersey, President and Chief Executive Officer of CASMED, will present an overview of the Company at the Friedman, Billings, Ramsey & Co., Inc. Spring Investor Conference on May 28, 2008 at the Grand Hyatt in New York, NY.
The presentation is scheduled to begin at 3:50 p.m. ET on Wednesday May 28 and will also be webcast live over the internet. The webcast may be accessed via the Company’s website at www.casmed.com, and will be accessible until August 28, 2008.
About CASMED® - Monitoring What’s Vital
CAS Medical Systems, Inc. manufactures medical devices for non-invasive patient monitoring. The Company’s newest innovative product is the FORE-SIGHT® Absolute Cerebral Oximeter the only cerebral oximeter with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition. CASMED’s initial market focus has been the adult cardiovascular OR, where nearly 700,000 high risk surgeries are performed each year in the U.S. In addition, a specialized sensor for neonatal/infant use will be commercially available in the third quarter of 2008 to address the nearly 40,000 babies born every year with congenital heart defects.
The Company’s product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Absolute Cerebral Oximeter; the low-acuity monitoring of its full line of vital signs monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.
For further information regarding CAS Medical Systems, Inc., visit the Company’s website at www.casmed.com.
CAS Medical Systems, Inc.
Director of Corporate Communications
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers and vendors, and other risks detailed in the Company’s Form 10-K for the year ended December 31, 2007 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.